Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Vesterhus

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
JHEP Reports : Innovation in Hepatology|February 2, 2024
Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitisEike Matthias Wacker, Florian Uellendahl-Werth, Saptarshi Bej, et al.
Clinical and Translational Gastroenterology|March 1, 2021
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing CholangitisLars Bossen, Mette Vesterhus, Johannes R Hov, et al.
JHEP Reports : Innovation in Hepatology|September 6, 2021
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELFGuri Fossdal, Anders B Mjelle, Kristine Wiencke, et al.
United European Gastroenterology Journal|June 8, 2017
Elevated trimethylamine-<i>N</i>-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver functionMartin Kummen, Mette Vesterhus, Marius Trøseid, et al.
Scientific Reports|June 13, 2019
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitisAmandeep K Dhillon, Andreas E Kremer, Martin Kummen, et al.
Scandinavian Journal of Gastroenterology|January 7, 2025
Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitisGuri Fossdal, Peder Braadland, Johannes Roksund Hov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2016
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitisJohannes R Hov, Kirsten M Boberg, Eli Taraldsrud, et al.
Scandinavian Journal of Gastroenterology|February 15, 2021
Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitisAmandeep Kaur Dhillon, Christian Rupp, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitisPeder Rustøen Braadland, Kai Markus Schneider, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|November 23, 2020
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver diseaseMette Vesterhus, Mette Juul Nielsen, Johannes Roksund Hov, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
JHEP Reports : Innovation in Hepatology|February 2, 2024
Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitisEike Matthias Wacker, Florian Uellendahl-Werth, Saptarshi Bej, et al.
Clinical and Translational Gastroenterology|March 1, 2021
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing CholangitisLars Bossen, Mette Vesterhus, Johannes R Hov, et al.
JHEP Reports : Innovation in Hepatology|September 6, 2021
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELFGuri Fossdal, Anders B Mjelle, Kristine Wiencke, et al.
United European Gastroenterology Journal|June 8, 2017
Elevated trimethylamine-<i>N</i>-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver functionMartin Kummen, Mette Vesterhus, Marius Trøseid, et al.
Scientific Reports|June 13, 2019
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitisAmandeep K Dhillon, Andreas E Kremer, Martin Kummen, et al.
Scandinavian Journal of Gastroenterology|January 7, 2025
Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitisGuri Fossdal, Peder Braadland, Johannes Roksund Hov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2016
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitisJohannes R Hov, Kirsten M Boberg, Eli Taraldsrud, et al.
Scandinavian Journal of Gastroenterology|February 15, 2021
Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitisAmandeep Kaur Dhillon, Christian Rupp, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitisPeder Rustøen Braadland, Kai Markus Schneider, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|November 23, 2020
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver diseaseMette Vesterhus, Mette Juul Nielsen, Johannes Roksund Hov, et al.
Pageof 6